I. Igerc

发表

Descriptive epidemiology of thyroid carcinoma in Carinthia, Austria: 1984-2001. Histopathologic features and tumor classification of 734 cases under elevated general iodination of table salt since 1990: population-based age-stratified analysis on thyroid carcinoma incidence.

W. Stronegger, H. Gallowitsch, E. Kresnik, 2004, Thyroid : official journal of the American Thyroid Association.

Posttherapeutic 131I SPECT-CT offers high diagnostic accuracy when the findings on conventional planar imaging are inconclusive and allows a tailored patient treatment regimen

M. Beheshti, P. Mikosch, H. Gallowitsch, 2009, European Journal of Nuclear Medicine and Molecular Imaging.

Combined PET/CT in the follow-up of differentiated thyroid carcinoma: what is the impact of each modality?

H. Gallowitsch, E. Kresnik, I. Gomez, 2007, European Journal of Nuclear Medicine and Molecular Imaging.

The Incremental Value of F‐18 FDG PET and PET/CT in Malignant Lymphoma

S. Kohlfuerst, H. Gallowitsch, P. Lind, 2008 .

The Impact of F‐18 Fluorodeoxyglucose PET on Diagnosis, Staging, Restaging, Therapy Planning and Prognosis of Non‐Small‐Cell Lung Cancer (NSCLC)

P. Mikosch, H. Gallowitsch, E. Kresnik, 2002 .

Worldwide 1st MED-EL Mi1200 SYNCHRONY cochlear implant magnet removal for MRI image artifact reduction

H. Eckel, Stefan Wieser, I. Igerc, 2018, Otolaryngology Case Reports.

Fluorine-18-fluorodeoxyglucose positron emission tomography in the preoperative assessment of thyroid nodules in an endemic goiter area.

H. Stettner, P. Mikosch, H. Gallowitsch, 2003, Surgery.

18F-FDG positron emission tomography in the early diagnosis of enterocolitis: preliminary results

D. Alberer, P. Mikosch, H. Gallowitsch, 2002, European Journal of Nuclear Medicine and Molecular Imaging.

Radioiodine Therapy: Malignant Thyroid Disease

S. Kohlfuerst, P. Lind, I. Igerc, 2007 .

Vocal cord muscle activity as a drawback to FDG-PET in the followup of differentiated thyroid cancer.

H. Haselbach, P. Mikosch, H. Gallowitsch, 2002, Thyroid : official journal of the American Thyroid Association.

Recombinant human thyrotropin is helpful in the follow-up and 131I therapy of patients with thyroid cancer: a report of the results and benefits using recombinant human thyrotropin in clinical routine.

P. Lind, I. Igerc, S. Kohlfuerst, 2005, Thyroid : official journal of the American Thyroid Association.

18F-FDG-PET in the follow-up of thyroid cancer.

E. Kresnik, I. Gomez, P. Lind, 2003, Acta medica Austriaca.

Is there a role for sandostatin treatment in patients with progressive thyroid cancer and iodine-negative but somatostatin-receptor-positive metastases?

H. Gallowitsch, E. Kresnik, I. Gomez, 2006, Thyroid : official journal of the American Thyroid Association.

Diagnosis, treatment and follow-up in the case of differentiated thyroid cancer

S. Kohlfuerst, P. Lind, I. Igerc, 2005, Wiener Medizinische Wochenschrift.

Clinical experience with a commercially available negative oral contrast medium in PET/CT.

K. Hausegger, P. Lind, Thomas Kau, 2005, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

Sentinel node SPECT-CT in breast cancer

P. Mikosch, H. Gallowitsch, E. Kresnik, 2007, Nuklearmedizin.

Receptor activator of nuclear factor κB ligand and osteoprotegerin in men with thyroid cancer

H. Stettner, P. Pietschmann, G. Grimm, 2006, European journal of clinical investigation.

Role of Fluorodeoxyglucose PET in Inflammatory Bowel Disease: A Review.

S. Kohlfuerst, P. Mikosch, H. Gallowitsch, 2006, PET clinics.

FDG PET helpful for diagnosing SAPHO syndrome.

P. Lind, I. Igerc, S. Kohlfuerst, 2003, Clinical nuclear medicine.

The value of 18F-Choline PET/CT in patients with elevated PSA-level and negative prostate needle biopsy for localisation of prostate cancer

S. Kohlfuerst, H. Gallowitsch, E. Kresnik, 2008, European Journal of Nuclear Medicine and Molecular Imaging.

Iodine Supplementation Fails to Target the Elderly: Perspectives from Austria

S. Kohlfuerst, H. Gallowitsch, P. Lind, 2009 .

Iodine supplementation in Austria: methods and results.

P. Mikosch, H. Gallowitsch, E. Kresnik, 2002, Thyroid : official journal of the American Thyroid Association.

The Value of Scintimammography, F‐18 FDG‐PET and PET‐CT in Breast Cancer

H. Gallowitsch, I. Igerc, 2005 .

F-18 Fluorodeoxyglucose Positron-Emission Tomography in the Diagnosis of Tumor Recurrence and Metastases in the Follow-Up of Patients With Breast Carcinoma: A Comparison to Conventional Imaging

Hans-Jürgen Gallowitsch, Ewald Kresnik, Johann Gasser, 2003, Investigative radiology.

The role of NM in thyroid and parathyroid diseases

I. Igerc, 2006 .

Advantages and limitations of FDG PET in the follow-up of breast cancer

Thomas Beyer, T. Beyer, Isabel Igerc, 2004, European Journal of Nuclear Medicine and Molecular Imaging.

Prostate biopsy guided by 18F-fluorocholine PET in men with persistently elevated PSA levels

P. Lind, I. Igerc, 2008, European Journal of Nuclear Medicine and Molecular Imaging.

The Role of F‐18 Choline PET and PET/CT in Prostate Cancer

S. Kohlfuerst, H. Gallowitsch, P. Lind, 2009 .

Kurz kommentiert - Clinical Experience with a Commercially Available Negative Oral Contrast Medium in PET/CT

K. Hausegger, P. Lind, Thomas Kau, 2005, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.